Department Of Clinical Pharmacy
Syllbus
THEORY | Practical | |||
---|---|---|---|---|
Quizzes | 5% | Quizzes | 5% | |
Mid term exam. | 20% | Mid term exam. | 20% | |
Cumulative | 50% | |||
final exam | 50% | |||
total | 100% |
week no. | subject | hours | outcome | Lecturer/date |
---|---|---|---|---|
1 | Introduction to clinical and community pharmacy: drug distribution system, principles of patient education | 3 | Define of clinical and community pharmacy with drug distribution patients education | Lecturer: Ali Jalal Shawkat |
2 | Clinical pharmacy practice in neonate pediatric and geriatric | 2 | Management of pediatric and geriatric | Lecturer: Ali Jalal Shawkat |
3 | Clinical pharmacy in respiratory system care: Cough common cold and allergic rhinitis. | 2 | Management of Cough, common cold and allergic rhinitis | Lecturer: Ali Jalal Shawkat |
4 | Clinical pharmacy in GIT system care: diarrhea, constipation, GERD and hemorrhoid. | 2 | Management of diarrhea, constipation, GERD and hemorrhoid. | Lecturer: Ali Jalal Shawkat |
5 | Pediatric care practice: oral thrush and head lice. | 2 | Oral thrush and head lice treatment | Lecturer: Ali Jalal Shawkat |
6 | Pharmacy care in skin conditions: acne, scabies, psoriasis, hair loss and athletes foot. | 2 | Pharmaceutical care of acne, scabies, psoriasis, hair loss and athletes foot. | Lecturer: Ali Jalal Shawkat |
7 | Women health care: cystitis and vaginal thrush, primary dysmenorrhea and emergency contraceptive techniques | 2 | Management of cystitis and vaginal thrush and mergency contraceptive techniques | Lecturer: Ali Jalal Shawkat |
8 | Pharmacy care in CNS related problems: headache, insomnia, and motions sickness. | 2 | Management of headache, insomnia, and motions sickness. | Lecturer: Ali Jalal Shawkat |
mid team exam | ||||
9 | Pharmacy care in eye disorders. | 1 | Eye disorders management | Lecturer: Ali Jalal Shawkat |
10 | Pharmacy care in ENT conditions. | 1 | ENT conditions treatment | Lecturer: Ali Jalal Shawkat |
11 | Pharmacy care in oral hygiene: mouth ulcer and mouth thrush. | 1 | mouth ulcer and mouth thrush treatment | Lecturer: Ali Jalal Shawkat |
12 | Pharmacy care in obesity and body weight control. | 2 | Controlling of weight and obesity treatment. | Lecturer: Ali Jalal Shawkat |
13 | Pharmacy care in management pain and musculoskeletal disorders. | 1 | Management of musculoskeletal disorders. | Lecturer: Ali Jalal Shawkat |
14 | Nicotine replacement therapy (NRT). | 2 | Advice and treatment of smoker persons | Lecturer: Ali Jalal Shawkat |
15 | Clinical pharmacy practice in poisoning. | 1 | Poisoning management. | Lecturer: Ali Jalal Shawkat |
16 | Clinical pharmacy practice in eczema and dermatitis; dandruff. | 2 | Medicines used for eczema and dermatitis; dandruff. | Lecturer: Ali Jalal Shawkat |
17 | Clinical pharmacy in fungal skin infection; cold sore, corns and callus | 2 | Management of skin infection | Lecturer: Ali Jalal Shawkat |
final exam |
THEORY | ||
---|---|---|
Quizzes | 5% | |
Mid term exam | 25% | |
Cumulative | 30% | |
Final exam | 70% | |
Total | 100% |
week NO. | subject | HOURES | outcome | LECTURER / date |
---|---|---|---|---|
1 | Concepts and principles of public health and preventive medicine. | 1 | Definition of public health and preventive medicine. | |
2 | Public health and statistics: Information for health care providers. | 1 | Give the information about biostatistics methods | |
3 | Epidemiology. | 2 | Definitions of epidemiology and diseases | |
4 | Communicable diseases: Infections through the gastro-intestinal tract. | 3 | Transmition of infectious diseases. | |
5 | Infections through skin and mucous membranes. | 3 | Management of skin and mucous membranes infections. | |
6 | Infections through the respiratory tract. | 3 | Treatment of respiratory tract infections. | |
Mid term exam | ||||
7 | Arthropod-borne infections. | 3 | Treatment of borne infections. | |
8 | Non-communicable disease: Health in transition. | 3 | Management of non-infectious diseases. | |
9 | Nutritional disorders. | 3 | Treatment of nutrition disorders. | |
10 | Family health. | 2 | Role of clinical pharmacy in personnel health | |
11 | Environmental health. | 3 | Effect of environment on public health | |
12 | Innate and acquired Immunity; Immunization. | 3 | Illustrate Iraqi immunization programs | |
Final Exam |
theory | practical | |||
---|---|---|---|---|
Quizzez | 5% | Quizzez | 5% | |
Mid term exam. | 20% | Mid term exam. | 20% | |
Cumulative | 50% | |||
final exam | 50% | |||
total | 100% |
NO. | subject | HOURES | outcome | lecturer/date |
---|---|---|---|---|
1 | Communication with patients | 2 | Learning how to communicate with patients | |
2 | Respiratory system in practice (part II): cough | 2 | Management of cough | |
3 | Respiratory system in practice (part II): common cold. | 2 | Management of common cold | |
4 | GIT system practice (part I): constipation. | 2 | Constipation management | |
5 | GIT system practice (part II): diarrhea and IBS | 2 | Diarrhea manegment | |
6 | GIT system practice (part III): GERD | 2 | GERD treatment | |
7 | Skin conditions in practice (part I): hair loss, cold sore and athlete’s foot | 2 | Management of hair loss, cold sore athletes foot | |
8 | Skin conditions in practice (part II): dandruff and eczema. | 2 | Dandruff and eczema treatment | |
mid term exam. | ||||
9 | Skin conditions in practice (part III): warts and scabies. | 2 | Wart and scabies treatment | |
10 | Collective practice number I. | 2 | Principles of pharmacy practice part I | |
11 | Pediatrics in practice: oral thrush, colic, pinworm and napkin rash. | 2 | oral thrush, colic, pinworm and napkin rash. Treatment | |
12 | Minor eye disorder in practice. | 2 | Eye disorder treatment | |
13 | Women health in practice. | 2 | Women health education | |
14 | Insomnia and motion sickness in practice. | 2 | Management of Insomnia and motion sickness | |
15 | Collective practice number II | 2 | Principles of pharmacy practice part II | |
final exam. |
theory | practical | |||
---|---|---|---|---|
Quizzez | 5% | Quizzez | 5% | |
Mid term exam. | 20% | Mid term exam. | 20% | |
Cumulative | 50% | |||
final exam | 50% | |||
total | 100% |
NO. | subject | HOURES | outcome | lecturer/date |
---|---|---|---|---|
1 | Clinical pharmacy process: Pharmaceutical care, pharmaceutical consultation, clinical pharmacy functions and knowledge. | 3 | Function of clinical pharmacist as a part of medical team | |
2 | Pharmacotherapy in hematologic disorders: Anemia. | 1 | Management of anemia | |
3 | Antimicrobial prophylaxis in surgery. | 1 | Surgical prophylaxis with antibiotics use | |
4 | Drug therapy in tuberculosis and infective endocarditis. | 2 | Treatment of TB | |
5 | Pharmacotherapy in infections: CNS infections. | 1 | Management of CNS infection | |
6 | Pharmacotherapy in bone and joints disorders: Gout and osteorarthritis. | 2 | Bone disorder treatment | |
7 | Drug therapy in rheumatoid arthritis and osteoporosis. | 2 | Treatment of OA | |
8 | Pharmacotherapy in endocrine disorders: Diabetes mellitus. | 2 | DM management | |
mid term exam. | ||||
9 | Drug therapy in adrenal gland disorders. | 2 | Management of adrenal disorder | |
10 | Prescribing concept in clinical pharmacy: Prescribing rational and effective prescribing, systematic approach to prescribing, strategies to improve prescribing, factors that influence the prescribing new medications. | 2 | Describe the effective prescription and factors influence medications | |
11 | Ethical consideration is clinical pharmacy practice. | 1 | Ethical learning in practice | |
12 | Drug therapy related problems. | 2 | Drugs related problem | |
13 | Clinical and economic impact of pharmaceutical care practice | 2 | Role of clinical pharmacist in care plan | |
14 | Adverse drug reactions: Mechanisms of dose-related (type A) adverse drug reactions, mechanisms of non-dose-related (type B) adverse drug reactions, detection and monitoring of adverse drug reactions, identification of adverse drug reactions. | 2 | Adverse drug reactions | |
15 | Alcohol abuse disorders, management of acute ethanol intoxication, and management of alcohol withdrawal. | 2 | Management of alcohol withdrawal | |
16 | Herbs and nutritional supplements, introduction and product labeling, herbalhazards, manufacturing(adulteration) and direct hazards, patient recommendations. | 3 | Role of herbs in treatment | |
final exam. |
theory | practical | |||
---|---|---|---|---|
Quizzez | 5% | Quizzez | 5% | |
Mid term exam. | 20% | Mid term exam. | 20% | |
Cumulative | 50% | |||
final exam | 50% | |||
total | 100% |
NO. | subject | HOURES | outcome | lecturer/date |
---|---|---|---|---|
1 | Communication with physician and patient counseling. | 2 | Build up communication skill with medical staff and patient | |
2 | Drugs for anemia and related disorders. | 2 | Management of anemia | |
3 | Cardiovascular drugs in practice part I. | 2 | Treatment of cardiovascular disease part I | |
4 | Cardiovascular drugs in practice part II. | 2 | Treatment of cardiovascular disease part II | |
5 | Cardiovascular drug in practice part III. | 2 | Treatment of cardiovascular disease part III | |
6 | Drugs for asthma and COPD in practice. | 2 | Management of asthma and COPD | |
7 | Antimicrobial drugs in practice part I. | 2 | Uses and types of antibiotics part I | |
mid term exam. | ||||
8 | Antimicrobial drugs in practice part II. | 2 | Uses and types of antibiotics part II | |
9 | Antimicrobial drugs in practice part III. | 2 | Uses and types of antibiotics part III | |
10 | Collective practice number I. | 2 | Pharmacy practice knowledge part I | |
11 | Drugs acting on CNS part I. | 2 | Drugs for CNS part I | |
12 | Drugs for musculoskeletal and joints diseases. | 2 | Treatment of musculoskeletal disorders | |
13 | Drugs for endocrine system part I (Diabetes Mellitus). | 2 | DM management part I | |
14 | Drugs for endocrine system part II (other endocrine drugs). | 2 | DM management part II | |
15 | Collective practice number I. | 2 | Pharmacy practice knowledge part II | |
final exam. |
theory | ||
---|---|---|
Quizzez | 5% | |
Mid term exam. | 25% | |
Cumulative | 30% | |
final exam | 70% | |
total | 100% |
NO. | subject | HOURES | outcome | lecturer/date |
---|---|---|---|---|
1 | Pharmacotherapy of Cardiovascular Disorders: Hypertension. | 2 | Management of hypertension | |
2 | Drug therapy in heart failure. | 2 | Management of heart failure | |
3 | Drug therapy in ischemic heart diseases and acute coronary syndrome. | 3 | Management of acute coronary syndrome | |
4 | Drug therapy in arrhythmias and stroke. | 2 | Management of stroke and arrhythmias | |
5 | Pharmacotherapy in dyslipidemia and venous thromboembolism. | 2 | Management of dyslipidemia | |
6 | Drug therapy in hypovolemic shock, intensive care (DKA). | 2 | Management of hypovolemic shock | |
7 | Pharmacotherapy of Respiratory disorders: Asthma and COPD. | 2 | Management of asthma and COPD | |
8 | Drug therapy in cystic fibrosis and upper and lower respiratory tract infections. | 2 | Management of lower respiratory tract infection | |
9 | Pharmacotherapy in gastrointestinal disorders: GERD and peptic ulcer diseases. | 2 | Management of GIT disorders | |
10 | Drug therapy in inflammatory bowel disease and irritable bowel syndrome. | 2 | Management of IBS and IBD | |
11 | Drug therapy in portal hypertension and liver cirrhosis, viral hepatitis. | 3 | Management of liver cirrhosis and hepatitis | |
mid term exam. | ||||
12 | Drug therapy in nausea and vomiting and pancreatitis. | 1 | Treatment of N/V | |
13 | Pharmacotherapy in renal disorders: Acute renal failure. | 2 | Management of acute renal failure | |
14 | Drug therapy in chronic end-stage renal diseases. | 3 | Management of end stage renal disease | |
15 | Drug therapy in fluid and electrolyte disorders and acid base disturbances; urinary tract infections. | 3 | Management of urinary tract infection and electrolyte disorder | |
16 | Drug therapy in urinary incontinence and pediatric enuresis. | 1 | Management of enuresis | |
17 | Drug therapy benign prostatic hyperplasia and erectile dysfunction. | 1 | Treatment of erectile dysfunctions | |
18 | Pharmacotherapy in neurologic disorders: epilepsy and status epilepticus. | 2 | Management of epilepsy and status epilepticus | |
19 | Drug therapy in multiple sclerosis; Parkinson disease and management of pain. | 2 | Management of MS, Parkinson disease | |
20 | Pharmacotherapy in gynecology and obstetrics disorders: Therapeutic considerations in pregnancy and lactation. | 2 | Treatment of gynecology and obstetrics disorders | |
21 | Drug therapy in menstruation related disorders; contraception. | 3 | Management of menstrual disorder | |
22 | Hormone replacement therapy in menopause. | 1 | Uses of HRT in menopause women | |
final exam. |
theory | ||
---|---|---|
Quizzez | 5% | |
Mid term exam. | 25% | |
Cumulative | 30% | |
final exam | 70% | |
total | 100% |
NO. | subject | HOURES | outcome | lecturer/date |
---|---|---|---|---|
1 | Drug therapy in adrenal gland disorders. | 2 | Management of adrenal gland disorders | |
2 | Drug therapy in hypothalamic-pituitary disorders. | 3 | Management of hypothalamic pituitary disorders | |
3 | Drug therapy in skin and soft tissue infections. | 1 | Management of skin and soft tissue infections | |
4 | Drug therapy in gastrointestinal and intra-abdominal infections. | 2 | Management of GIT disorders | |
5 | Drug therapy in sexually-transmitted diseases. | 2 | Management of STD | |
6 | Drug therapy in sepsis and septic shock. | 1 | Treatment of sepsis | |
7 | Drug therapy in parasitic infections. | 1 | Management of parasitic infections | |
8 | Drug therapy in invasive fungal infections. | 1 | Management of fungal infection | |
mid term exam. | ||||
9 | Drug therapy in HIV infection, other viral infections. | 2 | Treatment of HIV | |
10 | Interpretation of laboratory data | 2 | Explain and find relationship of lab. | |
11 | Parenteral nutrition : Total parentral nutrition (TPN), components and administration of TPN, pharmaceutical issues of TPN, nutritional assessment and monitoring | 3 | Data with disease | |
12 | Drug therapy in glaucoma and eye diseases | 2 | Management of glaucoma | |
13 | Drug therapy in schizophrenia | 2 | Management of schizophrenia | |
14 | Pharmacotherapy in oncologic disorders: Leukemia and lymphoma. | 2 | Management of leukemia | |
15 | Drug therapy in ovarian and breast cancers. | 1 | Management of breast CA | |
16 | Drug therapy in lung, prostate and colorectal cancers. | 2 | Management of colorectal CA | |
17 | Drug therapy in coagulation disorders and sickle cell disease. | 1 | Treatment of sickle cell anemia | |
final exam. |
THEORY | Practical | |||
---|---|---|---|---|
Quizzes | 5% | Quizzes | 5% | |
Mid term exam. | 20% | Mid term exam. | 20% | |
Cumulative | 50% | |||
final exam | 50% | |||
total | 100% |
week no. | subject | hours | outcome | Lecturer/date |
---|---|---|---|---|
1 | Principles of basic clinical pharmacokinetic parameters. | 2 | Study effect of body on drugs A,D,M,E | |
2 | Initiating treatment based on individualization approach. | 2 | Study the differences between individuals on pharmacokinetics principles | |
3 | Volume of distribution and target concentration of drug in the plasma. | 2 | Effect of Vd on drug concentrations and doses | |
4 | Continuing treatment: maintenance dose and clearance, factors affecting clearance. | 2 | Calculations of maintenance and loading doses | |
5 | Bioavailability and oral maintenance dosage regimen. | 2 | Drugs bioavailability in patients | |
6 | Stopping treatment: Elimination rate constant and plasma concentration-time profile, elimination half-life. | 3 | Calculation of t. half-life for drugs | |
7 | Variability in drug dosage requirements: effects of age, body weight, sex, renal function, liver function, genetic factors and drug interactions. | 3 | Study the factors effect on drug dose | |
8 | Therapeutic drug monitoring: Principles of TDM, timing of sample collection ,aminophyllin , digoxin, gentamicin , phenytoin, lidocaine . | 2 | TDM for essential medicines. | |
9 | Monitoring of anti-infective agents, immunosuppressants, anti-epileptic drugs, drugs used in psychiatry, anti-cancer drugs, digoxin and theophylline. | 3 | TDM for immunosupessants drugs | |
10 | Dosage regimen design: Intravenous bolus administration, intravenous infusion. | 3 | Study the differences between IV bolus and infusion | |
11 | Multiple dosage regimens (Repetitive dosing). | 2 | Calculation of dosage regimen | |
12 | Determination of route of administration. | 1 | Routes of drugs administration | |
13 | Dosing of drugs in infants and children, elderly and obese patient. | 2 | Drugs doses in infant and elderly patients | |
14 | Effect of food on drug disposition. | 1 | Foods effect on drugs absorption |
THEORY | Practical | |||
---|---|---|---|---|
Quizzes | 5% | Quizzes | 5% | |
Mid term exam. | 20% | Mid term exam. | 20% | |
Cumulative | 50% | |||
final exam | 50% | |||
total | 100% |
no. | subject | hours | outcome | Lecturer/date |
---|---|---|---|---|
1 | Effects of food on drug disposition | 2 | Food effect on drug absorption | |
2 | Dosing of drugs in the elderly | 2 | Doses in elderly patients | |
3 | Individualization of the dosage for obese patients | 4 | Doses in obese patients | |
4 | Pediatric pharmacokinetics | 4 | Pediatric A,D,M,E | |
5 | Review and tutorial | 2 | Training | |
6 | Dose individualization for high dose anti-cancer chemotherapy | 2 | Doses of anticancer chemotherapy | |
7 | Therapeutic drug monitoring of carbamazepine. | 4 | Carbamazepine TDM | |
8 | Therapeutic drug monitoring of cyclosporine | 4 | Cyclosporine TDM | |
9 | Therapeutic drug monitoring of psychotropic agents | 4 | Psychotropic medicines TDM | |
10 | Review and tutorial | 2 | Training |
no. | subject | hours | outcome | lecturer/date |
---|---|---|---|---|
1 | Clinical Pharmacy Practice in Internal Medicine: Clinical observation of cases; evaluation of the case sheets; case presentation; discussion and evaluation. | 20 | Clinical practice for internal medicines cases in wards | |
2 | Clinical Pharmacy Practice in Surgery wards: Clinical observation of cases; evaluation of the case sheets; case presentation; discussion and evaluation. | 20 | Clinical practice for surgery cases in wards | |
3 | Clinical Pharmacy Practice in Gynecology and Obstetrics Ward: Clinical observation of cases; evaluation of the case sheets; case presentation; discussion and evaluation. | 20 | Clinical practice for gynecology and obstetrics cases in wards |
THEORY | ||
---|---|---|
Quizzes | 5% | |
Mid term exam | 25% | |
Cumulative | 30% | |
Final exam | 70% | |
Total | 100% |
NO. | subject | HOURES | outcome | LECTURER / date |
---|---|---|---|---|
1 | Introduction to Pharmacy Ethics (Theoretical considerations). | 2 | Theory in pharmacy ethics | الصيدلانية الاختصاص شيماء احمد صميم |
2 | Code of Ethics for Pharmacists. | 1 | Learning of pharmacist how dealing with staff and patients | الصيدلانية الاختصاص شيماء احمد صميم |
3 | Common Ethical Considerations in Pharmaceutical Care Practice (Beneficence, Autonomy, Honesty, Informed Consent, Confidentiality, Fidelity). | 3 | Ethical considerations | الصيدلانية الاختصاص شيماء احمد صميم |
4 | Interprofessional Relations. | 2 | Pharmacist relationship with other medical team | الصيدلانية الاختصاص شيماء احمد صميم |
5 | Making ethical decisions. | 1 | Ethical decisions | الصيدلانية الاختصاص شيماء احمد صميم |
Mid term exam | ||||
6 | Ethical issues related to clinical pharmacy research. | 1 | Ethical issues in to clinical pharmacy research. | الصيدلانية الاختصاص الاء قصي عبد الستار |
7 | Ethical problems in the pharmacist’s clinical practice. | 1 | Ethical problems in clinical practice. | الصيدلانية الاختصاص الاء قصي عبد الستار |
8 | Preventing misuse of medicines. | 1 | Medication errors | الصيدلانية الاختصاص الاء قصي عبد الستار |
9 | Case studies in pharmacy ethics | 3 | Case studies in ethics | الصيدلانية الاختصاص الاء قصي عبد الستار |
Final Exam |
THEORY | ||
---|---|---|
Quizzes | 5% | |
Mid term exam | 25% | |
Cumulative | 30% | |
Final exam | 70% | |
Total | 100% |
NO. | subject | HOURES | outcome | LECTURER / date |
---|---|---|---|---|
1 | Principles and Elements of Interpersonal Communication | 2 | Elements of Interpersonal Communication | م. م صبا حميد |
2 | Nonverbal type of communication. | 2 | Nonverbal communication. | م. م صبا حميد |
3 | Barriers to communication. | 2 | Types of comm. Barriers | م. م صبا حميد |
4 | Listening and empathic responding during communication. | 2 | empathic responding during communication. | م. م صبا حميد |
5 | Assertiveness | 2 | pharmacists take an active role in patient care. | م. م صبا حميد |
6 | Interviewing and assessment. | 2 | Determining what patients understand about their medications, how they are taking their medications | م. م صبا حميد |
7 | Helping patients to manage therapeutic regimens.. | 2 | Advices on therapeutic medication regimen | م. م صبا حميد |
8 | Patient counseling; counseling check list point-by-point discussion; 2 counseling scenario. | 2 | Counseling scenario | م. م صبا حميد |
Mid term exam | ||||
9 | Medication safety and communication skills. | 2 | Medication safety | م. د مهند الساعدي |
10 | Strategies to meet specific needs. | 2 | special communication needs (older adults; persons with hearing, sight | م. د مهند الساعدي |
11 | Communicating with children and elderly about medications. | 2 | Understanding the Cognitive Developmental Level of a Child | م. د مهند الساعدي |
12 | Communication skills and inter-professional collaboration. | 2 | enhancing relationships between pharmacists and other health care providers | م. د مهند الساعدي |
13 | Electronic communication in healthcare. | 2 | use of electronic means of communication | م. د مهند الساعدي |
14 | Ethical behavior when communicating with patients. | 2 | how an ethical framework is often needed to guide their behavior when dealing with patients | م. د مهند الساعدي |
15 | Travel health | 1 | Patients review information about their destinations and itinerary and consider potential self-care options | م. د مهند الساعدي |
16 | Health insurance | 1 | Medical insurance | م. د مهند الساعدي |
Final Exam |
THEORY | practical | |||
---|---|---|---|---|
Quizzes | 5% | Quizzes | 5% | |
Mid term exam | 20% | final term exam | 20% | |
Cumulative | 50% | |||
Final exam | 50% | |||
Total | 100% |
NO. | subject | HOURES | outcome | LECTURER / date |
---|---|---|---|---|
1 | Introduction to the concept of clinical pharmacy- its activities and professional responsibilities. (Including current state of clinical pharmacy in Iraq). | 1 | Function of clinical pharmacist as a part of medical team | الصيدلاني الاختصاص حيدر الجوادي |
2 | Overview of pharmaceutical care practice (the patient care process). | 1 | Role of pharmacist in patient care process | الصيدلاني الاختصاص حيدر الجوادي |
3 | Hematologic disorders: Anemia and sickle cell disease. | 2 | Anemia types and managment | م. م علي جلال |
4 | Hypertension. | 2 | Treatment of hypertension | م. م علي جلال |
5 | Ischemic heart diseases | 2 | Management of IHD | م. م علي جلال |
6 | Heart failure. | 2 | Management of HF | م. م علي جلال |
7 | Peripheral vascular diseases. | 1 | Treatment of Peripheral vascular diseases. | الصيدلاني الاختصاص حيدر الجوادي |
8 | Asthma. | 2 | Asthma management | م. م علي جلال |
9 | Chronic obstructive pulmonary disease | 1 | Management of COPD | الصيدلاني الاختصاص حيدر الجوادي |
10 | Diabetes mellitus & Diabetic ketoacidosis (DKA) | 2 | Management of DKA | م. م علي جلال |
Mid term exam | ||||
11 | Peptic ulcer disease | 2 | Management of peptic ulcer | م. م علي جلال |
12 | Tuberculosis | 1 | Treatment of T.B | الصيدلاني الاختصاص حيدر الجوادي |
13 | Infective meningitis | 1 | Types and treatment of Infective meningitis | الصيدلاني الاختصاص حيدر الجوادي |
14 | Respiratory tract infections | 2 | Treatment of upper and lower RTI | م. م علي جلال |
15 | GIT infections | 1 | Management of GIT infection | الصيدلاني الاختصاص حيدر الجوادي |
16 | Gout and hyperuricemia | 1 | Management of hyperuricemia | الصيدلاني الاختصاص حيدر الجوادي |
17 | Rheumatoid arthritis (RA) and osteoarthritis (OA) | 2 | Treatment of RA and OA | م. م علي جلال |
18 | Osteoporosis and other metabolic bone disease | 1 | Management of osteoporosis | الصيدلاني الاختصاص حيدر الجوادي |
19 | Infectious Endocarditis | 1 | Management of endocarditis | الصيدلاني الاختصاص حيدر الجوادي |
20 | Surgical antibiotic prophylaxis | 1 | Antibiotics used preoperative | الصيدلاني الاختصاص حيدر الجوادي |
21 | Urinary tract infection (UTI) | 1 | Management of UTI | الصيدلاني الاختصاص حيدر الجوادي |
Final Exam |
THEORY | practical | |||
---|---|---|---|---|
Quizzes | 5% | Quizzes | 5% | |
Mid term exam | 20% | final term exam | 20% | |
Cumulative | 50% | |||
Final exam | 50% | |||
Total | 100% |
NO. | subject | HOURES | outcome | LECTURER / date |
---|---|---|---|---|
1 | Review of basic pharmacokinetic (PK) and pharmacodynamics (PD) | 2 | study of the absorption, distribution, Metabolism, and excretion of Drugs | م. د مهند الساعدي |
2 | Clinical PK equations and calculations | 3 | Clinical pharmacokinetic dosage calculations are conducted using the easiest possible equations and methods. | م. د مهند الساعدي |
3 | Clinical PK in special population and cases | 3 | change the pharmacokinetics of the drug and warrant dosage modification. | م. د مهند الساعدي |
4 | Clinical PK/PD for Aminoglycosides | 2 | Study The conventional method of dosing aminoglycoside antibiotics | م. د مهند الساعدي |
5 | Clinical PK/PD for Vancomycin | 2 | Study conc., Distribution steady state of vancomycin | م. د مهند الساعدي |
6 | Clinical PK/PD for Digoxin | 2 | Study Digoxin serum concentrations and PK in different dosage form | م. د مهند الساعدي |
Mid term exam | ||||
7 | Clinical PK/PD for Phenytoin | 3 | Study phenytoin serum concentrations and PK in different dosage form | م. د مهند الساعدي |
8 | Clinical PK/PD for other Anticonvulsants (e.g., Carbamazepine, Valproic Acid, Phenobarbitone/Primidone, Ethosuxsimide | 3 | Study anticonvulsants serum concentrations and PK | م. د مهند الساعدي |
9 | Clinical PK/PD for Theophylline | 2 | Study conc., Distribution steady state of theophylline | م. د مهند الساعدي |
10 | Clinical PK/PD for Immunossprasants (e.g., Cyclosporine, Tacrolimus | 2 | Study immunosupressants serum concentrations and PK | م. د مهند الساعدي |
11 | Clinical PK/PD for other Cardiovascular agents (e.g., Lidocaine, Procainamide/N-Acetyl Procainamide | 2 | Study cardiovascular agents serum concentrations and PK | م. د مهند الساعدي |
12 | Clinical PK/PD of other drugs (e.g., Lithium), Anticancer agents, and Anticoagulats | 4 | Study lithium antcancer and anticoagulants serum concentrations and PK | م. د مهند الساعدي |
Final Exam |
THEORY | ||
---|---|---|
Quizzes | 5% | |
Mid term exam | 25% | |
Cumulative | 30% | |
Final exam | 70% | |
Total | 100% |
NO. | subject | HOURES | outcome | LECTURER / date |
---|---|---|---|---|
1 | Course overview & basic principle of pharmacoeconomics | 2 | Main concept and definition of pharmacoeconomics | م.م صبا حميد |
2 | Cost analysis | 6 | Concept and definition and how to calculate cost analysis | م.م صبا حميد |
3 | Cost effectiveness analyses (CEA). | 2 | Concept and definition and how to calculate cost effectiveness analysis | م.م صبا حميد |
4 | Cost utility analyses (CUA). | 2 | Concept and definition and how to calculate cost utility analysis | م.م صبا حميد |
5 | Cost-benefit analysis (CBA) | 2 | Concept and definition and how to calculate cost benefit analysis | م.م صبا حميد |
Mid term exam | ||||
6 | Critical assessment of economic evaluation | 2 | Main assessment and evaluation of economic state in health system | م.م صبا حميد |
7 | Drug-focused versus disease-focused frame work for Conducting pharmacoeconomic analyses. | 2 | Different application done through different example on health system including drug versus disease according to pharmacoeconomics analysis concept | م.م صبا حميد |
8 | Introduction to epidemiology. | 2 | Main epidemiologic characteristic used in pharmacoeconomics | م.م صبا حميد |
9 | Project presentation. | 2 | Project about subject used pharmacoeconomy | م.م صبا حميد |
10 | Project presentation. | 2 | Project about subject used pharmacoeconomy in different view | م.م صبا حميد |
Final Exam |
THEORY | ||
---|---|---|
Quizzes | 5% | |
Mid term exam | 25% | |
Cumulative | 30% | |
Final exam | 70% | |
Total | 100% |
NO. | subject | HOURES | outcome | LECTURER / date |
---|---|---|---|---|
1 | Thyroid and parathyroid disorders | 2 | Disorders of thyroid and parathyroid glands | م. د مهند الساعدي |
2 | Contraception | 1 | Types and uses of contraceptives | م. د مهند الساعدي |
3 | Menstruation related disorders | 1 | Menstrual disorders | م. د مهند الساعدي |
4 | Hormonal replacement therapy (HRT) | 2 | HRT in women | م. د مهند الساعدي |
5 | Cancer treatment and chemotherapy | 2 | CA treatment and evaluation | م. د مهند الساعدي |
6 | Leukemias | 2 | Leukemias types and management | م. د مهند الساعدي |
7 | Breast and prostate cancers | 2 | Management of breast CA | م. د مهند الساعدي |
Mid term exam | ||||
8 | Adverse effects of chemotherapy | 1 | Chemotherapy adverse effect | م.م صبا حميد |
9 | Adrenal gland disorders | 1 | Disorders of adrenal glands | م.م صبا حميد |
10 | Alzheimer's disease | 1 | Treatment of Alzheimer disease | م.م صبا حميد |
11 | Schizophrenia | 2 | Schizophrenia management | م.م صبا حميد |
12 | Depressive disorders | 2 | Depressive disorders treatments | م.م صبا حميد |
13 | Anxiety disorders | 1 | Anxiety disorders management | م.م صبا حميد |
14 | Sleep disorders | 1 | Sleep disorders management | م.م صبا حميد |
Final Exam |
Staff Member
vission
To change the face of pharmacy through innovations that improves health
Mission
To advance the precise, safe, and effective use of medicines to improve health through excellence in patient care, education, research, and public service
SIENTFIC ACTIVITY DEPARTMENT
×
CV Of DR. Haitham Mahmoud

PERSONAL Information
EDUCATION BACKGROUND
×
CV Of DR. Sabaa

PERSONAL Information
EDUCATION BACKGROUND
×
CV Of DR. Mohanad

PERSONAL Information